November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

AI-Powered Single-Cell Atlas Identifies Cell Types Linked to Lung Cancer Metastasis Risk

🧠 AI Analysis 2 min read 👁 6

Researchers have created a machine learning model analyzing millions of tumor and microenvironment cells to better predict lung cancer progression and metastasis risk.

AI-Powered Single-Cell Atlas Identifies Cell Types Linked to Lung Cancer Metastasis Risk🧠AI Analysis

Photo: Medical Xpress

Key points

  • Researchers profiled gene activity across more than 2.5 million cells from 454 lung cancer patient samples to build the LuCaS+ single-cell atlas.
  • Machine learning models identified specific tumor and microenvironment cell interactions associated with a higher risk of cancer spread.
  • The predictive model succeeded in detecting early-stage patients at increased risk of relapse when validated against an independent cohort.

A team of researchers in Germany has developed an artificial intelligence framework that maps single-cell genetic activity from lung cancer tumors to better predict patient outcomes and the risk of disease spread. Published in the journal Nature Cancer by lead author Philipp Jurmeister and colleagues, the single-cell atlas—named LuCaS+—combines cell-level genetic profiles with long-term clinical data to identify cellular patterns linked to tumor aggressiveness.

Investigators from LMU Munich, Charité University Hospital Berlin, and the Technical University of Berlin evaluated archived tumor tissue from 454 lung cancer patients. Utilizing single-cell RNA sequencing, the team measured the activity of more than 2,000 genes per cell nucleus across more than 2.5 million individual cells. Machine learning algorithms then analyzed these cells alongside their surrounding microenvironment—including blood vessel, connective tissue, and immune system cells—to estimate metastatic potential. According to the study, the model identified individuals with early-stage tumors who had a higher risk of relapse than conventional evaluation methods indicated, findings that were subsequently confirmed in an independent cohort of patients.

What to know: Lung cancer displays significant internal diversity, meaning cells within the same tumor can differ markedly in behavior. Traditional staging relies primarily on tumor size and lymph node involvement, which may not capture cellular aggressiveness. While the model demonstrated improved predictive accuracy over standard metrics in retrospective data, the researchers note that the freely accessible LuCaS+ atlas is intended to help scientists identify new treatment targets for preliminary testing in laboratory and animal models. Patients should consult their healthcare team for personalized guidance regarding cancer diagnoses and treatment options.

Source Medical Xpress — medicalxpress.com/news/2026-11-ai-powered-lung-cancer-atlas.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.